Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
Gannie Tzoneva(Columbia University), Arianne Pérez-García(Columbia University), Zachary Carpenter(Columbia University), Hossein Khiabanian(Center for Systems Biology), Valeria Tosello(Istituto Oncologico Veneto), Maddalena Allegretta(Cancer Genetics (United States)), Elisabeth Paietta(Albert Einstein College of Medicine), Janis Racevskis(Albert Einstein College of Medicine), Jacob M. Rowe(Technion – Israel Institute of Technology), Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Maddalena Paganin(University of Padua), Giuseppe Basso(University of Padua), Jana Hof(Charité - Universitätsmedizin Berlin), Renate Kirschner‐Schwabe(Charité - Universitätsmedizin Berlin), Teresa Palomero(Columbia University Irving Medical Center), Raúl Rabadán(Center for Systems Biology), Adolfo A. Ferrando(Cancer Genetics (United States))
Cited by 350